Reading Time: 4 minutesThis is a guest blog by Kelly Siemund from the University of Leipzig in Germany. I am an early-career researcher in neuroscience, specifically working on
Category: Markers of Disease Progression
Reading Time: 6 minutesLast month we hosted our annual event for early career researchers (ECRs) in the UK. MND EnCouRage UK is a two day event which aims
Causes and disease mechanisms Events Genetic Research Get involved with research Healthcare Markers of Disease Progression MND Research Models of MND Research we fund
MND EnCouRage UK: Supporting the future leaders of MND research
Reading Time: 7 minutesIncreasing our understanding of MND, improving care and finding new potential treatments for the disease relies upon very talented and dedicated scientists working in MND
Reading Time: 6 minutesPlease note that this blog talks about sensitive topics such as death and tissue donation throughout. Researchers use many different tools to increase our understanding
34th Symposium: Basel Causes and disease mechanisms Markers of Disease Progression MND Research Symposium
Developing a potential microRNA blood test for ALS diagnosis
Reading Time: 4 minutesI’m Hannah, a PhD student from the University of Nottingham, and a Communications Ambassador for the 34th International Symposium on ALS/MND that took place in
Reading Time: 5 minutesHi, my name is Avril Mc Tague. I am undertaking a Ph.D. at Trinity College, Dublin, Ireland as part of the Multidisciplinary Innovation and Research Advancing Neurological care in a Digital Age (MIRANDA) doctoral award programme. This is funded by the Health Research Board in Ireland. I was one of five symposium communication ambassadors at last year’s international symposium.
Causes and disease mechanisms Genetic Research Markers of Disease Progression MND Research Models of MND Research we fund Treatments
Celebrating the contribution of Women to MND research
Reading Time: 7 minutesEach year the 11th of February sees the world recognise and celebrate the contributions of women in science. The International day of Women and Girls
34th Symposium: Basel Causes and disease mechanisms Clinical Trials Events Genetic Research Healthcare Markers of Disease Progression MND Research Symposium Treatments
Reuniting the MND community at the 34th International Symposium on ALS/MND
Reading Time: 4 minutesAfter 3 years of online events, the MND research and healthcare community reunited in-person at the 34th International Symposium on ALS/MND in Basel, Switzerland! From
34th Symposium: Basel Causes and disease mechanisms Markers of Disease Progression MND Research Symposium
Symposium Preview: Meet the ALS/FTD Plenary Speakers…Part 1
Reading Time: 5 minutesEvery year, the team works hard to build on the previous year’s success. This year we are excited to include a series of three ALS-FTD joint sessions, in collaboration with the International Society for Frontotemporal Dementias, in the programme.
Some people with ALS, the most common form of MND, also develop a form of dementia known as frontotemporal dementia (FTD). FTD is a group of disorders where the nerve cells in two sets of lobes (frontal and temporal) in the brain are damaged. In a similar way to how motor neurones break down in MND and cause loss of function in muscles, the damage to the nerve cells in FTD causes the connections between parts of the brain to break down. As more cells become damaged and die this can lead to symptoms such as problems with memory, thinking or language, changes in mood, emotions and behaviour.